From mechanics to robotics. We are very proud to shift our paradigm and join world class investors in a new adventure: Andrew Alliance. Another investment that goes towards our goal: make big Impact.
“We are delighted to expand our team of investors and partners with the industry’s most recognized companies,”said Piero Zucchelli, CEO and a co-founder of Andrew Alliance. “It’s particularly meaningful that both Tecan and Waters appreciate how we’re making robotics accessible to more scientists.”
In just four years, Andrew Alliance has become a leading choice for life science bench robotics. It’s relied on by 18 of the top 20 pharmaceutical companies, the top four diagnostic companies and 16 of the top 20 world’s leading academic research institutions.
Andrew Alliance is advancing science with a new class of high-performance, easy-to-use robots that dramatically improve the repeatability, performance and speed of liquid handling. This new approach and Andrew, the flagship robot, are winning awards and rapidly transforming bench research in hundreds of pharmaceutical, diagnostic and academic laboratories worldwide, by eliminating routine pipetting errors and time-consuming manual efforts.